{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:04:57Z","timestamp":1789787097835,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK087956"],"award-info":[{"award-number":["R01DK087956"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R56DK116887"],"award-info":[{"award-number":["R56DK116887"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK074038"],"award-info":[{"award-number":["P30DK074038"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM084147"],"award-info":[{"award-number":["GM084147"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX000820"],"award-info":[{"award-number":["I01BX000820"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01CX002391"],"award-info":[{"award-number":["I01CX002391"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX000851"],"award-info":[{"award-number":["BX000851"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015502","name":"Dialysis Clinics","doi-asserted-by":"publisher","award":["No number"],"award-info":[{"award-number":["No number"]}],"id":[{"id":"10.13039\/100015502","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006942","name":"Medical University of South Carolina","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006942","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Podocytes have a remarkable ability to recover from injury; however, little is known about the recovery mechanisms involved in this process. We recently showed that formoterol, a long-acting \u03b2<jats:sub>2<\/jats:sub>-adrenergic receptor (\u03b2<jats:sub>2<\/jats:sub>-AR) agonist, induced mitochondrial biogenesis (MB) in podocytes and led to renoprotection in mice. However, it is not clear whether this effect was mediated by formoterol acting through the \u03b2<jats:sub>2<\/jats:sub>-AR or if it occurred through \u201coff-target\u201d effects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We genetically deleted the \u03b2<jats:sub>2<\/jats:sub>-AR specifically in murine podocytes and used these mice to determine whether formoterol acting through the podocyte \u03b2<jats:sub>2<\/jats:sub>-AR alone is sufficient for recovery of renal filtration function following injury. The podocyte-specific \u03b2<jats:sub>2<\/jats:sub>-AR knockout mice (\u03b2<jats:sub>2<\/jats:sub>-AR<jats:sup>fl\/fl<\/jats:sup>\/PodCre) were generated by crossing \u03b2<jats:sub>2<\/jats:sub>-AR floxed mice with podocin Cre (B6.Cg-Tg(NPHS2-cre)295Lbh\/J) mice. These mice were then subjected to both acute and chronic glomerular injury using nephrotoxic serum (NTS) and adriamycin (ADR), respectively. The extent of injury was evaluated by measuring albuminuria and histological and immunostaining analysis of the murine kidney sections.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A similar level of injury was observed in \u03b2<jats:sub>2<\/jats:sub>-AR knockout and control mice; however, the \u03b2<jats:sub>2<\/jats:sub>-AR<jats:sup>fl\/fl<\/jats:sup>\/PodCre mice failed to recover in response to formoterol. Functional evaluation of the \u03b2<jats:sub>2<\/jats:sub>-AR<jats:sup>fl\/fl<\/jats:sup>\/PodCre mice following injury plus formoterol showed similar albuminuria and glomerular injury to control mice that were not treated with formoterol.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These results indicate that the podocyte \u03b2<jats:sub>2<\/jats:sub>-AR is a critical component of the recovery mechanism and may serve as a novel therapeutic target for treating podocytopathies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s43440-024-00594-5","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T05:01:42Z","timestamp":1714107702000},"page":"612-621","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Role of the \u03b22-adrenergic receptor in podocyte injury and recovery"],"prefix":"10.1007","volume":"76","author":[{"given":"Ehtesham","family":"Arif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish K.","family":"Solanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick G.","family":"Schnellmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Nihalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua H.","family":"Lipschutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,26]]},"reference":[{"key":"594_CR1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.12688\/f1000research.7255.1","volume":"5","author":"J Reiser","year":"2016","unstructured":"Reiser J, Altintas MM. Podocytes. F1000Res. 2016;5:114.","journal-title":"F1000Res"},{"issue":"2","key":"594_CR2","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1152\/physrev.00055.2006","volume":"88","author":"B Haraldsson","year":"2008","unstructured":"Haraldsson B, Nystrom J, Deen WM. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev. 2008;88(2):451\u201387.","journal-title":"Physiol Rev"},{"issue":"6","key":"594_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nrneph.2013.78","volume":"9","author":"PT Brinkkoetter","year":"2013","unstructured":"Brinkkoetter PT, Ising C, Benzing T. The role of the podocyte in albumin filtration. Nat Rev Nephrol. 2013;9(6):328\u201336.","journal-title":"Nat Rev Nephrol"},{"key":"594_CR4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3389\/fendo.2018.00409","volume":"9","author":"MA Lal","year":"2018","unstructured":"Lal MA, Patrakka J. Understanding podocyte biology to develop novel kidney therapeutics. Front Endocrinol. 2018;9:409.","journal-title":"Front Endocrinol"},{"issue":"4","key":"594_CR5","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.kint.2019.05.015","volume":"96","author":"E Torban","year":"2019","unstructured":"Torban E, Braun F, Wanner N, Takano T, Goodyer PR, Lennon R, et al. From podocyte biology to novel cures for glomerular disease. Kidney Int. 2019;96(4):850\u201361.","journal-title":"Kidney Int"},{"issue":"1","key":"594_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.mnh.0000199012.79670.0b","volume":"15","author":"RV Durvasula","year":"2006","unstructured":"Durvasula RV, Shankland SJ. Podocyte injury and targeting therapy: an update. Curr Opin Nephrol Hypertens. 2006;15(1):1\u20137.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"2","key":"594_CR7","doi-asserted-by":"publisher","first-page":"F322","DOI":"10.1152\/ajprenal.00533.2019","volume":"318","author":"P Bhargava","year":"2020","unstructured":"Bhargava P, Janda J, Schnellmann RG. Elucidation of cGMP-dependent induction of mitochondrial biogenesis through PKG and p38 MAPK in the kidney. Am J Physiol Renal Physiol. 2020;318(2):F322\u20138.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"594_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/nep.13584","volume":"24","author":"E Arif","year":"2019","unstructured":"Arif E, Nihalani D. Beta2-adrenergic receptor in kidney biology: a current prospective. Nephrology. 2019;24(5):497\u2013503.","journal-title":"Nephrology"},{"issue":"1","key":"594_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1124\/jpet.118.252833","volume":"369","author":"RB Cameron","year":"2019","unstructured":"Cameron RB, Gibbs WS, Miller SR, Dupre TV, Megyesi J, Beeson CC, et al. Proximal tubule beta 2-adrenergic receptor mediates formoterol-induced recovery of mitochondrial and renal function after ischemia-reperfusion injury. J Pharmacol Exp Ther. 2019;369(1):173\u201380.","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"594_CR10","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1128\/MCB.05234-11","volume":"31","author":"DB Johnstone","year":"2011","unstructured":"Johnstone DB, Zhang JZ, George B, Leon C, Gachet C, Wong H, et al. Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy. Mol Cell Biol. 2011;31(10):2162\u201370.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"594_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2332\/allergolint.11-RAI-0317","volume":"60","author":"N Hizawa","year":"2011","unstructured":"Hizawa N. Pharmacogenetics of beta2-agonists. Allergol Int. 2011;60(3):239\u201346.","journal-title":"Allergol Int"},{"issue":"1","key":"594_CR12","first-page":"8","volume":"39","author":"Syamsu","year":"2007","unstructured":"Syamsu, Yusuf I, Patellongi I. The effect of polymorphism of the beta-2 adrenergic receptor on the response to beta-2 agonist in bronchial asthma patients. Acta Med Indones. 2007;39(1):8\u201312.","journal-title":"Acta Med Indones"},{"issue":"1","key":"594_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jaci.2005.11.012","volume":"117","author":"M Johnson","year":"2006","unstructured":"Johnson M. Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation. J Allergy Clin Immunol. 2006;117(1):18\u201324.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"594_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000339271","volume":"122","author":"SB Wachter","year":"2012","unstructured":"Wachter SB, Gilbert EM. Beta-adrenergic receptors, from their discovery and characterization through their manipulation to beneficial clinical application. Cardiology. 2012;122(2):104\u201312.","journal-title":"Cardiology"},{"issue":"3","key":"594_CR15","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.kint.2019.03.023","volume":"96","author":"E Arif","year":"2019","unstructured":"Arif E, Solanki AK, Srivastava P, Rahman B, Fitzgibbon WR, Deng P, et al. Mitochondrial biogenesis induced by the beta2-adrenergic receptor agonist formoterol accelerates podocyte recovery from glomerular injury. Kidney Int. 2019;96(3):656\u201373.","journal-title":"Kidney Int"},{"issue":"1","key":"594_CR16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3390\/ijms21010274","volume":"21","author":"AK Solanki","year":"2020","unstructured":"Solanki AK, Srivasta P, Rahman B, Lipschutz JH, Nihalani D, Arif E. The Use of high-throughput transcriptomics to identify pathways with therapeutic significance in podocytes. Int J Mol Sci. 2020;21(1):274.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"594_CR17","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1083\/jcb.200809113","volume":"183","author":"E Hinoi","year":"2008","unstructured":"Hinoi E, Gao N, Jung DY, Yadav V, Yoshizawa T, Meyers MG, et al. The sympathetic tone mediates leptin\u2019s inhibition of insulin secretion by modulating osteocalcin bioactivity. J Cell Biol. 2008;183(7):1235\u201342.","journal-title":"J Cell Biol"},{"key":"594_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2019.113064","volume":"322","author":"NE Scholpa","year":"2019","unstructured":"Scholpa NE, Simmons EC, Tilley DG, Schnellmann RG. Beta2-adrenergic receptor-mediated mitochondrial biogenesis improves skeletal muscle recovery following spinal cord injury. Exp Neurol. 2019;322: 113064.","journal-title":"Exp Neurol"},{"issue":"7","key":"594_CR19","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1681\/ASN.2016111166","volume":"28","author":"JCQ Velez","year":"2017","unstructured":"Velez JCQ, Arif E, Rodgers J, Hicks MP, Arthur JM, Nihalani D, et al. Deficiency of the angiotensinase aminopeptidase A increases susceptibility to glomerular injury. J Am Soc Nephrol. 2017;28(7):2119\u201332.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"594_CR20","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1172\/JCI27414","volume":"116","author":"R Verma","year":"2006","unstructured":"Verma R, Kovari I, Soofi A, Nihalani D, Patrie K, Holzman LB. Nephrin ectodomain engagement results in Src kinase activation, nephrin phosphorylation, Nck recruitment, and actin polymerization. J Clin Invest. 2006;116(5):1346\u201359.","journal-title":"J Clin Invest"},{"issue":"14","key":"594_CR21","doi-asserted-by":"publisher","first-page":"9502","DOI":"10.1074\/jbc.M113.505743","volume":"289","author":"E Arif","year":"2014","unstructured":"Arif E, Rathore YS, Kumari B, Ashish F, Wong HN, Holzman LB, et al. Slit diaphragm protein Neph1 and its signaling: a novel therapeutic target for protection of podocytes against glomerular injury. J Biol Chem. 2014;289(14):9502\u201318.","journal-title":"J Biol Chem"},{"issue":"1","key":"594_CR22","doi-asserted-by":"publisher","first-page":"12047","DOI":"10.1038\/s41598-017-12134-8","volume":"7","author":"A Sagar","year":"2017","unstructured":"Sagar A, Arif E, Solanki AK, Srivastava P, Janech MG, Kim SH, et al. Targeting Neph1 and ZO-1 protein-protein interaction in podocytes prevents podocyte injury and preserves glomerular filtration function. Sci Rep. 2017;7(1):12047.","journal-title":"Sci Rep"},{"issue":"6","key":"594_CR23","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/S0002-9440(10)63247-6","volume":"165","author":"A Masszi","year":"2004","unstructured":"Masszi A, Fan LF, Rosivall L, McCulloch CA, Rotstein OD, Muscsi I, et al. Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. Am J Pathol. 2004;165(6):1955\u201367.","journal-title":"Am J Pathol"},{"issue":"3","key":"594_CR24","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1046\/j.1523-1755.1998.00076.x","volume":"54","author":"YY Ng","year":"1998","unstructured":"Ng YY, Huang TP, Yang WC, Chen ZP, Yang AH, Mu W, et al. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5\/6 nephrectomized rats. Kidney Int. 1998;54(3):864\u201376.","journal-title":"Kidney Int"},{"issue":"6","key":"594_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217585","volume":"14","author":"TG Lopes","year":"2019","unstructured":"Lopes TG, Souza ML, Silva VD, Santos MD, Silva WIC, Itaquy TP, et al. Markers of renal fibrosis: how do they correlate with podocyte damage in glomerular diseases? PLoS ONE. 2019;14(6): e0217585.","journal-title":"PLoS ONE"},{"issue":"7\u20138","key":"594_CR26","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00424-017-1993-z","volume":"469","author":"J Muller-Deile","year":"2017","unstructured":"Muller-Deile J, Schiffer M. Podocytes from the diagnostic and therapeutic point of view. Pflugers Arch. 2017;469(7\u20138):1007\u201315.","journal-title":"Pflugers Arch"},{"issue":"9","key":"594_CR27","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nm.1857","volume":"14","author":"C Faul","year":"2008","unstructured":"Faul C, Connelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med. 2008;14(9):931\u20138.","journal-title":"Nat Med"},{"issue":"2","key":"594_CR28","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1046\/j.1523-1755.2000.00213.x","volume":"58","author":"SJ Shankland","year":"2000","unstructured":"Shankland SJ, Eitner F, Hudkins KL, Goodpaster T, D\u2019Agati V, Alpers CE. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation. Kidney Int. 2000;58(2):674\u201383.","journal-title":"Kidney Int"},{"issue":"1","key":"594_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/ki.2011.306","volume":"81","author":"A Fukuda","year":"2012","unstructured":"Fukuda A, Wickman LT, Venkatareddy MP, Sato Y, Chowdhury MA, Wang SQ, et al. Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease. Kidney Int. 2012;81(1):40\u201355.","journal-title":"Kidney Int"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-024-00594-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-024-00594-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-024-00594-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T04:13:50Z","timestamp":1716524030000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-024-00594-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["594"],"URL":"https:\/\/doi.org\/10.1007\/s43440-024-00594-5","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,26]]},"assertion":[{"value":"7 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal studies were approved under the protocol number Protocol # IACUC-2018-00360 by the MUSC IACUC (Institutional Animal Care and Use Committee) and were conducted as per the NIH guidelines for Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}